Strategic Opportunity Assessment
Our team assessed the top 20% of DRGs with the highest cost to the US healthcare system, to provide strategic background for assessing enterprise-wide global project plans.
A large medical device company with multiple divisions needs strategic tools to assess enterprise-wide global project plans. These tools must assess the greatest areas of unmet need in a framework that can be applied to each division in the enterprise.
- How do we measure and define the greatest areas of medtech opportunity?
- How can we design innovative devices that improve clinical need and economic outcomes where most needed?
Reviewed Medicare data to assess the top 100 DRGs with the highest cost to the US healthcare system
- Annual US Medicare spend
- Cost of devices/supplies
- Length of stay in dollars and days
Created a 40-page analysis synthesizing 4000 pages of US Medicare spend in the top 100 DRGs with the highest cost to the US healthcare system.
Based on the requirements and strategic focus of the client, we grouped the 100 DRGs to match corporate structure, and then analyzed each group for opportunity.